Michelle Irvin

<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Teresa I. Ng, Preethi Krishnan, Warren M. Kati et al. · Antimicrobial Agents and Chemotherapy · 2017 · 139 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

<i>In Vitro</i> Activity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase Inhibitor

Warren M. Kati, Gennadiy Koev, Michelle Irvin et al. · Antimicrobial Agents and Chemotherapy · 2014 · 123 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

<i>In Vitro</i> and <i>In Vivo</i> Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450

Rakesh Tripathi, Daniel E. Cohen, I. Gaultier et al. · Antimicrobial Agents and Chemotherapy · 2014 · 117 citations

Life Sciences, Infectious Diseases, Pharmacology +17

Resistance Analysis of Baseline and Treatment-Emergent Variants in Hepatitis C Virus Genotype 1 in the AVIATOR Study with Paritaprevir-Ritonavir, Ombitasvir, and Dasabuvir

Preethi Krishnan, Rakesh Tripathi, Gretja Schnell et al. · Antimicrobial Agents and Chemotherapy · 2015 · 95 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

Teresa I. Ng, Rakesh Tripathi, Thomas Reisch et al. · Antimicrobial Agents and Chemotherapy · 2017 · 91 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13